Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about disclosure

09 Nov 2026 Evaluate
Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust. 

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1875.00
Dr. Reddys Labs. 1371.85
Cipla 1394.60
Lupin 1981.60
Zydus Lifesciences 1200.55
View more..